{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-054496","form_type":"8-K","ticker":"ATEC","cik":"0001350653","company_name":"Alphatec Holdings, Inc.","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.214914+00:00","generated_at":"2026-06-28T12:44:09.404393+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Alphatec Q3 revenue $62.9M (+53% total, +29% organic); FY21 rev guidance ~$235M (+62%)","bullets":["Q3 total revenue $62.9M, up 53% YoY; organic revenue rose 29%; GAAP operating loss $35.1M.","Non-GAAP gross margin 72%; adjusted EBITDA loss $9.8M; cash balance $223.9M.","Lateral PTP technique drove >50% of Q3 revenue growth; surgeon users up 20% vs Q3 2020.","EOS imaging contributed >$11M in Q3; FY21 EOS revenue expected ~$26M.","Convertible debt raised net $188M; FY21 total revenue guidance ~$235M (+62% vs prior year)."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-054496","json":"https://secwatch.observer/filing/0001564590-21-054496.json","markdown":"https://secwatch.observer/filing/0001564590-21-054496.md","text":"https://secwatch.observer/filing/0001564590-21-054496.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1350653/000156459021054496/0001564590-21-054496-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1350653/000156459021054496/atec-8k_20211104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T12:44:09.404393+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}